Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

NCT00560066 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1398

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza
Vaccine

Interventions

BIOLOGICAL: Cell-derived influenza vaccine
BIOLOGICAL: Egg-derived influenza vaccine

Sponsor

Novartis Vaccines